Holen Sie sich die Stockscreener-App
3.06
7.18%
0.205
Handel nachbörslich:
3.06
Schlusskurs vom Vortag:
$2.855
Offen:
$2.86
24-Stunden-Volumen:
5.30M
Relative Volume:
0.53
Marktkapitalisierung:
$224.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.83M
KGV:
-3.8734
EPS:
-0.79
Netto-Cashflow:
$-20.87M
1W Leistung:
+51.49%
1M Leistung:
+264.29%
6M Leistung:
+567.68%
1J Leistung:
+338.40%
1-Tages-Spanne:
$2.79
$3.095
1-Wochen-Bereich:
$1.949
$3.83
52-Wochen-Spanne:
$0.2223
$3.83
Cognition Therapeutics Inc Stock (CGTX) Company Profile
Firmenname
Cognition Therapeutics Inc
Sektor
Branche
Telefon
412-481-2210
Adresse
2403 SIDNEY STREET, PITTSBURGH
Vergleichen Sie CGTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGTX
Cognition Therapeutics Inc
|
3.06 | 209.76M | 0 | -22.83M | -20.87M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Cognition Therapeutics Inc Stock (CGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-07-30 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-11-03 | Eingeleitet | B. Riley Securities | Buy |
| 2021-11-03 | Eingeleitet | Oppenheimer | Outperform |
Cognition Therapeutics Inc Aktie (CGTX) Neueste Nachrichten
How to manage a losing position in Cognition Therapeutics Inc.2025 Bull vs Bear & AI Powered Market Trend Analysis - Newser
Cognition Therapeutics Inc. stock trend outlook and recovery pathWeekly Trend Report & Accurate Intraday Trading Signals - Newser
Can Cognition Therapeutics Inc. hit a new high this monthJuly 2025 Opening Moves & Real-Time Buy Signal Alerts - Newser
Cognition Therapeutics Inc. stock retracement – recovery analysisOil Prices & Fast Entry and Exit Trade Plans - Newser
Automated trading signals detected on Cognition Therapeutics Inc.Entry Point & AI Powered Buy/Sell Recommendations - Newser
Cognition Therapeutics regains Nasdaq compliance with $1 share price By Investing.com - Investing.com Canada
Is Cognition Therapeutics Inc. still worth holding after the dipQuarterly Performance Summary & Weekly High Return Stock Opportunities - Newser
Cognition Therapeutics shares rise 1.58% premarket after regaining compliance with Nasdaq. - AInvest
Cognition Therapeutics regains Nasdaq compliance on $1.00 bid price rule - MSN
Using economic indicators to assess Cognition Therapeutics Inc. potentialMarket Risk Report & Verified Technical Trade Signals - Newser
Cognition Therapeutics regains Nasdaq compliance with $1 share price - Investing.com India
What technical models suggest about Cognition Therapeutics Inc.’s comebackWeekly Trade Summary & AI Powered Buy and Sell Recommendations - Newser
Cognition Therapeutics Regains Nasdaq Compliance - TipRanks
Volatility clustering patterns for Cognition Therapeutics Inc.Market Risk Analysis & Free Low Drawdown Momentum Trade Ideas - Newser
Cognition Therapeutics Regains Compliance With Nasdaq's Minimum Bid Price Rule - MarketScreener
Cognition Therapeutics: A Nasdaq-Compliant Biotech Poised to Disrupt Alzheimer's Therapeutics - AInvest
Cognition Therapeutics regains compliance with Nasdaq minimum bid price requirement - MarketScreener
Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Neurodegenerative Drug Developer Cognition Therapeutics Maintains Nasdaq Listing After Price Recovery - Stock Titan
How moving averages guide Cognition Therapeutics Inc. tradingQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - Newser
Real time scanner hits for Cognition Therapeutics Inc. explained2025 Price Targets & Scalable Portfolio Growth Ideas - Newser
Cognition Therapeutics Inc. Faces Market Upheaval Amidst Strategic Developments - StocksToTrade
Earnings Chart Overlay Points to Cognition Therapeutics Inc. Upside getLinesFromResByArray error: size == 0 - kangso.co.kr
Trend analysis for Cognition Therapeutics Inc. this weekMarket Performance Summary & Accurate Trade Setup Notifications - Newser
Cognition: Zervimesine AD Treatment Program FDA Alignment Means "Strong Buy" Rating (NASDAQ:CGTX) - Seeking Alpha
Does Cognition Therapeutics Inc. show high probability of reboundJuly 2025 Reactions & Long-Term Growth Plans - Newser
How high can Cognition Therapeutics Inc. stock goRate Cut & Consistent Return Strategy Ideas - Newser
Identifying reversal signals in Cognition Therapeutics Inc.Fed Meeting & Accurate Entry/Exit Alerts - Newser
Leading vs lagging indicators on Cognition Therapeutics Inc. performanceTrade Risk Report & Weekly Top Gainers Trade List - Newser
Cognition Therapeutics shares rise 1.82% after-hours following positive clinical data presentations by Stoke Therapeutics and Biogen. - AInvest
Published on: 2025-08-26 05:03:52 - 더경남뉴스
Forecasting Cognition Therapeutics Inc. price range with options data2025 Retail Activity & High Accuracy Trade Signal Alerts - Newser
Cognition Therapeutics Inc. recovery potential after sell offJuly 2025 Volume & Smart Investment Allocation Insights - Newser
Is Cognition Therapeutics Inc. building a consolidation baseWeekly Stock Report & High Accuracy Swing Entry Alerts - Newser
How Cognition Therapeutics Inc. stock performs during market volatility2025 Market Outlook & Safe Entry Momentum Stock Tips - Newser
Cognition Therapeutics Inc. stock trend forecastMarket Growth Review & Consistent Profit Trading Strategies - Newser
Support Zone Holds Steady for Cognition Therapeutics Inc. After DipJuly 2025 PostEarnings & Real-Time Volume Analysis - Newser
Cognition Therapeutics Inc. Reaches Critical Trendline SupportPortfolio Gains Report & Low Drawdown Investment Ideas - beatles.ru
Cognition Therapeutics Inc. Stock Lags Behind Sector BenchmarksWatch List & Verified Momentum Stock Watchlist - 더경남뉴스
Cognition Therapeutics shares rise 2.51% premarket after Silo Pharma's Alzheimer's candidate SPC-14 featured in Alzheimer’s Research & Therapy. - AInvest
Cognition Therapeutics Inc. stock outlook for YEAR2025 Volatility Report & AI Powered Trade Plan Recommendations - Newser
Technical Models Suggest Cognition Therapeutics Inc. May Rebound SoonJuly 2025 Earnings & Reliable Intraday Trade Alerts - 더경남뉴스
Applying Elliott Wave Theory to Cognition Therapeutics Inc.Gold Moves & Short-Term Swing Trade Alerts - Newser
Cognition Therapeutics shares rise 1.93% intraday after Nature Aging study links FTL1 protein reduction to reversing age-related memory loss. - AInvest
Cognition Therapeutics shares rise 14.60% intraday after Nature Aging study shows potential for reversing age-related memory loss and company's expansion of zervimesine treatment for Lewy body dementia. - AInvest
What makes Cognition Therapeutics Inc. stock price move sharplyQuarterly Earnings Summary & Long-Term Safe Investment Ideas - Newser
Cogitation Therapeutics Gears Up for Promising Phase 3 Trials - StocksToTrade
Drawdown in Cognition Therapeutics Inc. May Be Nearing EndRate Hike & Entry and Exit Point Strategies - thegnnews.com
Finanzdaten der Cognition Therapeutics Inc-Aktie (CGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):